11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection
RxNorm concept 1927885, clinical drug (scd). Prescribable name: riTUXimab 1400 MG / hyaluronidase, human recombinant 23,400 UNT in 11.7 ML Injection.
- RxCUI
- 1927885
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927885 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML Injection; riTUXimab 1400 MG / hyaluronidase, human recombinant 23,400 UNT per 11.7 ML Injection; rituximab 1400 MG / hyaluronidase, human recombinant 23,400 UNT per 11.7 ML Injection
Related concepts
- hyaluronidase, human recombinant 2000 UNT/ML (SCDC, consists of)
- rituximab 120 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1927885 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927885 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1927885. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.